HCPLive Network

Poor Sleep Connected to Obesity, Diabetes, and Heart Disease

Poor Sleep Connected to Obesity, Diabetes, and Heart DiseasePoor sleep is connected to a significantly increased risk for major cardiovascular and metabolic disorders, such as obesity, diabetes, and coronary artery disease, researchers at the University of Pennsylvania’s Perelman School of Medicine have found.

The researchers studied data on 138,201 individuals from the Behavioral Risk Factor Surveillance System, an annual telephone survey carried out by the Centers for Disease Control and Prevention. After adjusting for demographic, socioeconomic, medical, and psychological factors, they found that patients who suffered sleep disturbances at least three nights per week were 35% more likely to be obese, 54% more likely to have diabetes, 98% more likely to have coronary artery disease, 80% more likely to suffer a heart attack, and 102% more likely to have a stroke.

“Previous studies have demonstrated that those who get less sleep are more likely to also be obese, have diabetes or cardiovascular disease, and are more likely to die sooner, but this new analysis has revealed that other sleep problems, such as difficulty falling asleep, staying asleep, or even too much sleep, are also associated with cardiovascular and metabolic health issues,” the study’s lead author, Michael A. Grandner, PhD, said in a press release.

The researchers added that future studies should focus on whether sleep intervention has the potential to reduce the cardiometabolic consequences of sleep disturbance.

The study was published online ahead of print last month in the Journal of Sleep Research.
Further Reading
Physicians and health care providers must be aware of their potential liability when ordering screening tests, according to an article published July 24 in Medical Economics.
Every year, more and more Americans are diagnosed with type 2 diabetes mellitus and, according to a recent study, in the near future that number could reach close to 40% of the population.
An emerging epidemic of acute hepatitis C threatens the country’s younger population, which experienced a significant hike in the number of cases during a recent 6 year period, according to a compound study that looked at trends of the disease among youth.
A new drug was given tentative approval by the US Food and Drug Administration to help patients with both type 1 and type 2 diabetes.
There is a strong association between severe untreated obstructive sleep apnea and resistant elevated blood pressure, despite treatment with an aggressive antihypertensive medication regimen, according to a study published in the August issue of the Journal of Clinical Sleep Medicine.
Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.
The urban food initiative seems to be a safe and ethical approach to addressing obesity and food insecurity, according to a viewpoint piece published online Aug. 18 in JAMA Pediatrics.
More Reading